| BioID | bio3391 |
| Name | FUTIBATINIB |
| ChEMBL ID | CHEMBL3701238 |
| Molecular Formula | C22H22N6O3 |
| Molecular Weight | 418.46 |
| Molecular Weight (Monoisotopic) | 418.1753 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar18 |
| Target Name | Serine/threonine-protein kinase cot (COT) |
| Synonyms | FGFR-IN-1|FUTIBATINIB|LYTGOBI|TAS 120|TAS-120 |
| Smiles | C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1 |
| Inchi | InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1 |
| Inchi Key | KEIPNCCJPRMIAX-HNNXBMFYSA-N |
| Molecular Species | NEUTRAL |
| Targets | 22.0 |
| Bioactivities | 56.0 |
| Np Likeness Score | -0.8 |
| Records Key | ['FUTIBATINIB', 'BDBM161389', 'FUTIBATINIB', 'Futibatinib', 'COVC-3907758474', '1; TAS-120', 'FUTIBATINIB', 'FUTIBATINIB', 'TAS-120', '5; TAS-120', '25; TAS-120'] |
| Records Name | ['FUTIBATINIB', 'US9108973, 2', 'FUTIBATINIB', 'Futibatinib', 'FUTIBATINIB', '(S)-1-(3-(4-Amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one', 'FUTIBATINIB', 'FUTIBATINIB', '(S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one', 'Futibatinib; (S)-1-(3-(4-amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one', '1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one'] |
| Withdrawn Flag | False |
| Orphan | 0 |